4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002561
Chief Medical Officer gave up 2,861 shares (to pay taxes)
- Chief Medical Officer acquired 9,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rottinghaus Scott T. · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-12 | Grant or award : show line 1 in the form | +9,750 | 27,668 | D | ||
| 2025-02-12 | Shares withheld for taxes : show line 2 in the form | −2,861 | $5.59 | $15,993 | 24,807 | D |
Loading xslF345X05/form4.xml…